What is Medchart?
Medchart operates as a specialized technology platform designed to optimize the medical record retrieval process. By automating the intake and authorization workflow, the company enables legal practitioners to reclaim valuable time previously lost to manual administrative tasks. Its core value proposition lies in its ability to interface with 98% of healthcare facilities across the country, effectively removing the friction associated with traditional record acquisition. Medchart is not merely a service provider but a strategic partner for firms seeking to improve case efficiency and operational throughput through advanced digital infrastructure.
How much funding has Medchart raised?
Medchart has raised a total of $17M across 1 funding round:
Other Financing Round
$17M
Other Financing Round (2021): $17M with participation from Vast Ventures, Golden Ventures, Nas, Union Square Ventures, iGan Partners, Crosslink Capital, and Stanford Law School
Key Investors in Medchart
Vast Ventures
Vast Ventures is a manifesto-driven venture fund that invests in disruptive companies aimed at creating a global impact, with a specific focus on improving worldwide health and human productivity.
Golden Ventures
Golden Venture Partners is a mobile-focused seed and early-stage venture capital fund that provides mentorship and capital to entrepreneurs leveraging the potential of mobile products and services.
Union Square Ventures
Union Square Ventures is a New York City-based venture capital firm that invests in transformative markets influenced by technological and societal changes, partnering with visionary entrepreneurs to build the future.
What's next for Medchart?
With the recent influx of capital, Medchart is well-positioned to transition into a phase of aggressive market expansion and product diversification. The strategic focus will likely center on deepening its integration capabilities with existing legal practice management software and expanding its footprint within the healthcare ecosystem. By prioritizing the scalability of its SMART authorization engine, the company aims to solidify its status as the industry standard for medical data exchange. Future growth will be driven by the continued adoption of its platform among enterprise-level legal firms that require high-volume, reliable, and compliant record retrieval solutions to maintain a competitive edge in litigation and claims management.
See full Medchart company page
